• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。

The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.

机构信息

School of Pharmacy and Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, 422C Mellon Hall, Pittsburgh, PA, 15282, USA.

出版信息

Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.

DOI:10.1007/s11095-023-03547-4
PMID:37389801
Abstract

Amorphous solid dispersions (ASDs) are a formulation and development strategy that can be used to increase the apparent aqueous solubility of poorly water-soluble drugs. Their implementation, however, can be hindered by destabilization of the amorphous form, as the drug recrystallizes from its metastable state. Factors such as the drug-polymer solubility, miscibility, mobility, and nucleation/crystal growth rates are all known to impact the physical stability of an ASD. Non-covalent interactions (NCI) between the drug and polymer have also been widely reported to influence product shelf-life. In this review, the relationship between thermodynamic/kinetic factors and adhesive NCI is assessed. Various types of NCIs reported to stabilize ASDs are described, and their role in affecting physical stability is examined. Finally, NCIs that have not yet been widely explored in ASD formulations, but may potentially impact their physical stability are also briefly described. This review aims to stimulate further theoretical and practical exploration of various NCIs and their applications in ASD formulations in the future.

摘要

无定形固体分散体 (ASD) 是一种制剂和开发策略,可用于提高水溶性差的药物的表观水溶性。然而,由于药物从亚稳定状态重结晶,无定形形式的不稳定性可能会阻碍其实施。众所周知,药物-聚合物的溶解度、混溶性、迁移率和成核/晶体生长速率等因素都会影响 ASD 的物理稳定性。药物和聚合物之间的非共价相互作用 (NCI) 也被广泛报道会影响产品的保质期。在这篇综述中,评估了热力学/动力学因素与粘性 NCI 之间的关系。描述了各种类型的 NCI 被报道用于稳定 ASD,研究了它们在影响物理稳定性方面的作用。最后,还简要描述了在 ASD 制剂中尚未广泛探索但可能影响其物理稳定性的 NCI。本综述旨在激发对各种 NCI 的进一步理论和实践探索,以及它们在未来 ASD 制剂中的应用。

相似文献

1
The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。
Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.
2
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
3
Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.无定形固体分散体的物理稳定性:热力学、动力学和环境方面的物理化学视角。
Pharm Res. 2018 Apr 23;35(6):125. doi: 10.1007/s11095-018-2408-3.
4
Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?将晶型和聚合型辅料组合在原料药固体分散体中-机遇还是风险?
Eur J Pharm Biopharm. 2021 Jan;158:323-335. doi: 10.1016/j.ejpb.2020.11.025. Epub 2020 Dec 6.
5
Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.药物-聚合物溶解度和混溶性的分析和计算方法。
Mol Pharm. 2021 Aug 2;18(8):2835-2866. doi: 10.1021/acs.molpharmaceut.1c00141. Epub 2021 May 27.
6
A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.用于预测无定形固体分散体物理稳定性的机械模型。
J Pharm Sci. 2021 Apr;110(4):1495-1512. doi: 10.1016/j.xphs.2020.08.006. Epub 2020 Aug 18.
7
Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).预测和构建无定形固体分散体(ASD)中药物-聚合物二元体系的热力学相图。
AAPS PharmSciTech. 2022 Jun 17;23(6):169. doi: 10.1208/s12249-022-02319-4.
8
An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.聚合物载体在无定形固体分散体系中晶体生长作用的研究。
Mol Pharm. 2015 Apr 6;12(4):1180-92. doi: 10.1021/mp500702s. Epub 2015 Mar 6.
9
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
10
Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.药物-聚合物溶解度在理解研磨导致固体分散体不稳定方面的分子影响
Mol Pharm. 2014 Jul 7;11(7):2453-65. doi: 10.1021/mp500205c. Epub 2014 Jun 13.

引用本文的文献

1
High-Throughput Microarray Approaches for Predicting the Stability of Drug-Polymer Solid Dispersions.用于预测药物-聚合物固体分散体稳定性的高通量微阵列方法
Mol Pharm. 2025 Jan 6;22(1):343-362. doi: 10.1021/acs.molpharmaceut.4c00955. Epub 2024 Dec 21.
2
Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients.无定形固体分散体:药物活性成分及辅料的制备方法和物理化学性质的影响
Pharmaceutics. 2024 Aug 2;16(8):1035. doi: 10.3390/pharmaceutics16081035.
3
Understanding the Influence of API Conformations on Amorphous Dispersion Formation Potential Predictions using the 3 Molecular Descriptor.

本文引用的文献

1
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions.聚乙烯亚胺的结构修饰以控制无定形固体分散体的载药和释放特性
Mol Pharm. 2023 Mar 6;20(3):1779-1787. doi: 10.1021/acs.molpharmaceut.2c00970. Epub 2023 Jan 31.
2
Investigating and Comparing the Applicability of the R3m Molecular Descriptor and Solubility Parameter Estimation Approaches in Predicting Dispersion Formation Potential of APIs in a Random Co-Polymer Polyvinylpyrrolidone Vinyl Acetate and its Homopolymer.研究并比较R3m分子描述符和溶解度参数估算方法在预测活性药物成分在无规共聚物聚乙烯吡咯烷酮-醋酸乙烯酯及其均聚物中形成分散体潜力方面的适用性。
J Pharm Sci. 2023 Jan;112(1):318-327. doi: 10.1016/j.xphs.2022.11.004. Epub 2022 Nov 14.
3
利用3种分子描述符理解活性药物成分构象对无定形分散体形成潜力预测的影响。
Mol Pharm. 2024 Feb 5;21(2):770-780. doi: 10.1021/acs.molpharmaceut.3c00909. Epub 2024 Jan 5.
4
Influence Mechanism of Drug-Polymer Compatibility on Humidity Stability of Crystalline Solid Dispersion.药物-聚合物相容性对结晶固体分散体湿度稳定性的影响机制
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1640. doi: 10.3390/ph16121640.
Combining drug salt formation with amorphous solid dispersions - a double edged sword.将药物盐形成与无定形固体分散体相结合——一把双刃剑。
J Control Release. 2022 Dec;352:47-60. doi: 10.1016/j.jconrel.2022.09.056. Epub 2022 Oct 15.
4
Implications of Coexistent Halogen and Hydrogen Bonds in Amorphous Solid Dispersions on Drug Solubility, Miscibility, and Mobility.无定形固体分散体中共存的卤键和氢键对药物溶解度、混溶性和迁移性的影响。
Mol Pharm. 2022 Nov 7;19(11):3959-3972. doi: 10.1021/acs.molpharmaceut.2c00434. Epub 2022 Sep 1.
5
Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State.在玻璃态下开发物理稳定的高载药量 API-聚合物无定形固体分散体时需要考虑的因素。
J Pharm Sci. 2023 Jan;112(1):8-18. doi: 10.1016/j.xphs.2022.08.007. Epub 2022 Aug 7.
6
Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.水稳定性药物-聚合物相互作用有助于非洛地平无定形固体分散体溶解过程中纳米物种的形成。
Mol Pharm. 2022 Aug 1;19(8):2888-2899. doi: 10.1021/acs.molpharmaceut.2c00250. Epub 2022 Jun 27.
7
Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.通过聚合物盐形成改善肠溶性聚合物及其无定形固体分散体的溶出度。
Int J Pharm. 2022 Jun 25;622:121886. doi: 10.1016/j.ijpharm.2022.121886. Epub 2022 Jun 1.
8
Crystallization Propensity of Amorphous Pharmaceuticals: Kinetics and Thermodynamics.无定形药物的结晶倾向:动力学和热力学。
Mol Pharm. 2022 Feb 7;19(2):472-483. doi: 10.1021/acs.molpharmaceut.1c00839. Epub 2022 Jan 3.
9
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca.无定形固体分散体:在阿斯利康临床前药物开发中的利用和挑战。
Int J Pharm. 2022 Feb 25;614:121387. doi: 10.1016/j.ijpharm.2021.121387. Epub 2021 Dec 18.
10
Interpreting the Physicochemical Meaning of a Molecular Descriptor Which Is Predictive of Amorphous Solid Dispersion Formation in Polyvinylpyrrolidone Vinyl Acetate.解读对预测聚维酮醋酸乙烯酯无定形固体分散体形成有影响的分子描述符的物理化学意义。
Mol Pharm. 2022 Jan 3;19(1):303-317. doi: 10.1021/acs.molpharmaceut.1c00783. Epub 2021 Dec 21.